Compound ID | 936
Synonym(s): OPC 17116
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Institute where first reported: | Otsuka Pharmaceuticals, Japan; GSK, USA |
| Year first mentioned: | 1991 |
| Highest developmental phase: | Approved by FDA in 1997 |
| Development status: | Discontinued |
| Reason Dropped: | Withdrawn from market world-wide due to lengthening QT interval resulting in cardiac abnormalities and death |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/72474 |
| Guide to Pharmacology: | grepafloxacin |
| Citation: | https://journals.asm.org/doi/10.1128/aac.36.3.573 |